Global Marine Omega-3 Market Strategic Research Report

Scope of the Report

The global Marine Omega-3 market size is predicted to grow from US$ 2,970 million in 2025 to US$ 4,052 million in 2032; it is expected to grow at a CAGR of 4.6% from 2026 to 2032.

Marine Omega-3, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of Marine Omega-3 involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.

Global Marine Omega-3 key players include DSM, BASF, GC Rieber Oils, KD Pharma Group, Pelagia (EPAX), etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 55%, followed by South America, with a share about 20 percent. In terms of product, Marine Animals Source Omega-3 is the largest segment, with a share about 90%. And in terms of application, the largest application is Dietary Supplements, followed by Pet Foods, Fortified Food and Beverage, Infant Formula, Pharmaceuticals, etc.

This report presents a comprehensive overview of the global Marine Omega-3 market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Marine Animals Source Omega-3
• Marine Plant Source Omega-3

Segment by Application

• Dietary Supplements
• Fortified Food and Beverage
• Infant Formula
• Pharmaceuticals
• Pet Foods
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Marine Omega-3 market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Dietary Supplements, Fortified Food and Beverage, Infant Formula evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact